Cargando…
Ki-67 Index Provides Long-Term Survival Information for Early-Stage HER2-Low-Positive Breast Cancer: A Single-Institute Retrospective Analysis
AIM: It has been reported that more than half of breast cancer (BC) could be identified as HER2-low-positive, which might be a distinct subtype. But the results are controversial. We aim to compare the survival outcomes between HER2-low-positive and HER2-0 BC with Asian women based on HR status or K...
Autores principales: | Qi, Wei-Xiang, Chen, Lingyan, Cao, Lu, Xu, Cheng, Cai, Gang, Chen, Jiayi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489376/ https://www.ncbi.nlm.nih.gov/pubmed/36147446 http://dx.doi.org/10.1155/2022/4364151 |
Ejemplares similares
-
Integration of Ki-67 index into AJCC 2018 staging provides additional prognostic information in breast tumours candidate for genomic profiling
por: Vissio, Elena, et al.
Publicado: (2019) -
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
por: Cheang, Maggie C. U., et al.
Publicado: (2009) -
Prognostic impact of discrepant Ki67 and mitotic index on hormone receptor-positive, HER2-negative breast carcinoma
por: Rossi, L, et al.
Publicado: (2015) -
Incorporation of p-53 mutation status and Ki-67 proliferating index in classifying Her2-neu positive gastric adenocarcinoma
por: Ahmed, Ayesha, et al.
Publicado: (2018) -
Ki-67 immuno-histochemistry index in stage III giant cell tumor of the bone
por: Ismail, Faisham W, et al.
Publicado: (2010)